The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Expected Market Size Of The Whole Genome And Exome Sequencing Market From 2026 To 2030?
In recent years, the whole genome and exome sequencing market has experienced exponential growth in its size. This market is projected to expand from $2.52 billion in 2025 to $3.14 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 24.8%. Historically, this expansion has been driven by several factors, including progress in next-generation sequencing technologies, the rising application of genomics in cancer research, the broadening of academic genomics initiatives, a reduction in sequencing expenses, and the proliferation of precision medicine programs.
The market for whole genome and exome sequencing is projected to experience substantial expansion over the upcoming years. This market is predicted to reach $7.63 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 24.8%. Several factors are driving this anticipated growth, including the expanding implementation of extensive genomics initiatives, the increasing incorporation of AI in genomic interpretation, broader acceptance of clinical genomics, escalating investments in sequencing infrastructure, and a surging need for tailored treatment approaches. Key developments expected during this timeframe encompass a greater embrace of comprehensive genome sequencing, a heightened application of sequencing in cancer diagnostics, an increasing requirement for unified WGS and WES workflows, an expansion in population genomics research, and an intensified emphasis on high-throughput sequencing technologies.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp
What Drivers Are Influencing The Whole Genome And Exome Sequencing Market?
The increasing need for personalized medicine is projected to stimulate the growth of the whole genome and exome sequencing market in the future. Personalized medicine defines a medical treatment method that tailors healthcare choices and interventions to each patient’s unique attributes, considering aspects such as genetics, environment, and lifestyle. Whole genome and exome sequencing plays a role in personalized medicine by offering a thorough analysis of an individual’s genetic makeup, thereby enabling customized healthcare decisions and interventions based on their specific genetic, environmental, and lifestyle elements. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based organization dedicated to promoting the understanding and adoption of personalized medicine, announced that the FDA approved 26 personalized medicines, which included 20 new molecular entities (NMEs) and 6 gene-/cell-based therapies, collectively representing roughly 38% of all newly approved therapeutic NMEs. Thus, the escalating demand for personalized medicine is propelling the expansion of the whole genome and exome sequencing market.
Which Segments Are Included In The Analysis Of The Whole Genome And Exome Sequencing Market?
The whole genome and exome sequencing market covered in this report is segmented –
1) By Product Type: Kits, Instruments
2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research, Other Applications
4) By End user: Research Center, Academic And Government Institutions, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Kits: Library Preparation Kits, Target Enrichment Kits, DNA Extraction Kits
2) By Instruments: Next-Generation Sequencing (NGS) Systems, Sanger Sequencing Systems, Third-Generation Sequencing Systems
What Key Trends Are Influencing The Development Of The Whole Genome And Exome Sequencing Market?
Major companies active in the whole genome and exome sequencing markets are intensifying their efforts to develop sophisticated technological solutions, like ultra-fast NGS analysis, to secure a competitive advantage. Ultra-fast NGS analysis is a technological advancement that allows for extremely rapid processing of next-generation sequencing (NGS) data, considerably shortening the time needed for genomic data analysis. For example, in January 2023, QIAGEN Digital Insights (QDI), a US-based bioinformatics company, unveiled its ultra-fast NGS analysis platform. This platform is capable of processing a whole genome in 25 minutes for $1 in cloud computing costs, thereby fostering efficiency, affordability, and scalability; its technological ingenuity greatly enhances genomic data analysis speed and accessibility, rendering it critically important in the whole genome and exome sequencing market by enabling prompt decision-making and broader acceptance of personalized medicine.
Which Key Industry Participants Are Active In The Whole Genome And Exome Sequencing Market?
Major companies operating in the whole genome and exome sequencing market are Siemens AG, Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Cytiva (Danaher Corporation), Laboratory Corporation of America Holdings, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V, BGI Genomics, Novogene Co., Oxford Nanopore Technologies Inc., Pacific Biosciences of California Inc., GENEWIZ Inc., 10x Genomics Inc., MGI Tech Co. Ltd., Clear Labs Inc., Macrogen Inc., PierianDx Inc., Invitae Corporation, Fulgent Genetics Inc., SOPHiA GENETICS SA, Azenta US Inc., Gene by Gene Ltd.
Read the full whole genome and exome sequencing market report here:
Which Regions Are Expected To Experience Rapid Expansion In The Whole Genome And Exome Sequencing Market?
North America was the largest region in the whole genome and exome sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the whole genome and exome sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Whole Genome And Exome Sequencing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13957&type=smp
Browse Through More Reports Similar to the Global Whole Genome And Exome Sequencing Market 2026, By The Business Research Company
Whole Exome Sequencing Global Market Report
https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report
Next Generation Sequencing Market
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-market
Dna Sequencing Global Market Report
https://www.thebusinessresearchcompany.com/report/dna-sequencing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model